Home » Learning Objectives, Emerging Risks for Old Medications, CATR, May/June 2020

Learning Objectives, Emerging Risks for Old Medications, CATR, May/June 2020

June 10, 2020

After reading these articles, you should be able to:

Characterize the hazards of non-benzodiazepine sedative-hypnotic medications (“Z-drugs”).

Assess for and treat the unhealthy use of benzodiazepines and gabapentinoids.

Describe the mechanisms, side effects, and risks of commonly prescribed muscle relaxants.

Summarize some of the findings in the literature regarding addiction treatment

Addiction Treatment

Treating Opioid Use Disorder—A Fact Book (2024)
All the tools you need to assess and treat patients struggling with opioid use disorder.
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

General Psychiatry
Psychopharm Secrets: Coming Off Meds
There’s a hidden placebo response to watch for when patients stop meds on their own.
Listen now

Join Our Writing Team
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024

Join Our Writing Team
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024

Join Our Writing Team
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024